Funded Tech Companies
IM Therapeutics
IM Therapeutics is a leading biopharmaceutical company, based in Woburn. Financial backing was provided by Morningside Group, CU Healthcare Innovation Fund and JDRF T1D Fund.
Company Overview
Company Name
IM Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
299 Washington St. A
Woburn, MA 01801
USA
Woburn, MA 01801
USA
Phone
Website
Email Address
Company Background Information
Overview
IMT is the first company to target the root cause of autoimmunity with therapeutic design directed at HLA variants known to confer high disease risk. The Company platform builds drug molecules for specific blockade of an HLA protein in a given autoimmune disease as a novel paradigm in drug development.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/10/2019
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nandan Padukone
Chief Medical Officer
Peter Gottlieb
Chief Scientific Officer
Aaron Michels
VP - R & D
Robert Perni
Company Investors
- Morningside Group (Jason Dinges)
- CU Healthcare Innovation Fund
- JDRF T1D Fund (Sean Doherty)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs